이 팟캐스트 소개 🔗

진행자:
업데이트 빈도:
daily
평균 오디오 길이:
50 minutes
게스트 인터뷰
영어
미국
에피소드 947 개
2020년 12월 4일부터
episodic

AUDIENCE OF THIS PODCAST 🔗

~78.12% of listeners are from United States.
🇺🇸
US
78.12%
🇸🇬
SG
8.12%
🇨🇦
CA
4.68%
🇩🇪
DE
2.50%
🇬🇧
GB
1.56%
🇦🇺
AU
1.25%
🇳🇱
NL
0.93%
🇮🇪
IE
0.62%
🇭🇰
HK
0.62%
🇳🇿
NZ
0.31%
🇪🇸
ES
0.31%
🇵🇭
PH
0.31%
🇯🇴
JO
0.31%
🇮🇹
IT
0.31%
Others
0.05%
* Data source: directly measured on Listen Notes. 실시간

최신 에피소드 🔗

Send us Fan Mail What happens when centuries-old Jewish traditions meet modern industrial design? Can reinventing the objects we use actually help preserve the traditions they represent?Today, we're going to explore a fascinating intersection of entrepreneurship, industrial design, branding, a…

과거 에피소드 검색

Progress, Potential, and Possibilities Podcast / Show의 과거 에피소드를 검색하세요.

이전 에피소드

Send us Fan Mail What happens when GPS goes dark?No satellites. No reliable positioning signals. And an aircraft still needs to know exactly where it is.What if the answer has been hiding in the Earth's magnetic field all along?Luca Ferrara is General Manager of Navigation at SandboxAQ ( https…
Send us Fan Mail Finding the right treatment isn't simply about choosing a medication. It's about understanding the patient, the condition, the risks, and what success actually looks like in everyday life. That's particularly challenging when we're talking about ADHD and and neu…
Send us Fan Mail Nuclear power has a scale problem: conventional plants are enormous, expensive projects that can take years to build. Hadron Energy wants to take a different approach with a factory-manufactured, 10-megawatt light-water microreactor. But can a smaller reactor actually mean lower co…
Send us Fan Mail The world doesn't have a shortage of promising medical discoveries. The real challenge is turning those discoveries into safe, effective, accessible treatments. What separates a breakthrough idea from a successful therapy? How could AI change the economics of drug development?…
Send us Fan Mail What if we stopped thinking about antibodies as simply drugs that bind to one target - and started thinking about them as engineered molecular machines? Today we're talking about a bispecific antibody that targets both EGFR and LGR5, and asking whether that kind of antibody en…
Send us Fan Mail What happens when you're 19 years old, physically fit, a collegiate wrestler, and you suddenly find yourself hospitalized for three days with influenza? Today's guest, Zachery Lang, experienced exactly that - and his story offers an important perspective on a disease many…
Send us Fan Mail Homelessness, addiction, mental health, aging and incarceration are often treated as separate problems. But for the people experiencing them, they're frequently connected. What would it take to build a system that sees the whole person - and could emerging technology help us g…
Send us Fan Mail What if the next breakthrough in diabetes treatment isn't necessarily a new drug molecule, but a better way to deliver the drugs we already have? One biotechnology company is developing a platform designed to target the liver with insulin - and exploring whether the same princ…
Send us Fan Mail Cancer medicine is advancing rapidly. But are patients getting the tests and treatments they need to benefit from those advances?Chronic lymphocytic leukemia, or CLL, is one of the most common forms of adult leukemia. And while advances in targeted therapies have transformed the tr…
면책 조항: 이 페이지에 포함된 팟캐스트와 작품은 Ira Pastor에서 가져온 것입니다. 이 팟캐스트는 소유자의 재산이며 Listen Notes, Inc.와 제휴하거나 보증하지 않습니다.